ROR1

Assets acting on this target.

Class
Antibody-drug conjugate targeting ROR1
Notes
mechanism wave 2026-08-24 (DeepSeek draft; cited page names the drug and the target); source: https://www.merck.com/research/pipeline/

Related mechanisms

ROR1 drugs compared

2 drugs, stage by indication
2 drugs acting on ROR1: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Zilovertamab vedotinMerck & Co.antibody-drug conjugatePhase 2/3Phase 2/3 in Diffuse Large B-Cell Lymphoma
IM-1021Immunome, Inc.antibody-drug conjugatePhase 1Not recorded

← all mechanisms